Search
Markets
News
Analysis
Tools
Stock Screener
Learn
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
nasdaq-trvi
/
Trevi Therapeutics Inc
TRVI
Add to Watchlist
17.610
USD
-1.040
-5.58%
Close 07/01, 16:00(ET)
Quotes delayed by 15 min
17.610
USD
+17.610
After-hours 07/01, 20:00 (ET)
2.26B
Market Cap
Loss
P/E TTM
Trevi Therapeutics Inc
17.610
-1.040
-5.58%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
New Enterprise Associates (NEA)
9.31%
Frazier Life Sciences Management, L.P.
7.23%
BlackRock Institutional Trust Company, N.A.
5.68%
Fidelity Management & Research Company LLC
4.58%
Vivo Capital, LLC
3.59%
Other
69.61%
Shareholders
Shareholders
Proportion
New Enterprise Associates (NEA)
9.31%
Frazier Life Sciences Management, L.P.
7.23%
BlackRock Institutional Trust Company, N.A.
5.68%
Fidelity Management & Research Company LLC
4.58%
Vivo Capital, LLC
3.59%
Other
69.61%
Shareholder Types
Shareholders
Proportion
Investment Advisor
34.94%
Investment Advisor/Hedge Fund
21.93%
Venture Capital
14.98%
Hedge Fund
11.20%
Private Equity
9.47%
Research Firm
2.84%
Individual Investor
0.64%
Bank and Trust
0.41%
Pension Fund
0.30%
Other
3.27%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
339
142.75M
101.53%
-5.97M
2025Q4
299
136.35M
106.46%
+9.18M
2025Q3
272
116.14M
95.37%
+14.43M
2025Q2
232
94.28M
77.42%
+5.93M
2025Q1
226
89.66M
76.74%
+2.50M
2024Q4
177
80.67M
91.74%
+11.34M
2024Q3
156
59.14M
78.18%
-6.31M
2024Q2
148
56.93M
80.80%
-4.85M
2024Q1
147
52.57M
76.38%
-8.69M
2023Q4
131
54.54M
85.48%
-544.63K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
New Enterprise Associates (NEA)
13.22M
10.3%
--
--
Feb 13, 2026
Frazier Life Sciences Management, L.P.
10.26M
7.99%
--
--
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
8.07M
6.29%
+699.44K
+9.49%
Dec 31, 2025
Fidelity Management & Research Company LLC
6.50M
5.06%
+3.20M
+96.96%
Dec 31, 2025
Vivo Capital, LLC
5.09M
3.97%
--
--
Dec 31, 2025
Marshall Wace LLP
4.58M
3.57%
-261.20K
-5.39%
Dec 31, 2025
Rubric Capital Management LP
3.77M
2.93%
-4.77M
-55.85%
Dec 31, 2025
Wellington Management Company, LLP
3.40M
2.65%
+150.10K
+4.61%
Dec 31, 2025
MPM BioImpact LLC
3.29M
2.56%
-119.87K
-3.52%
Dec 31, 2025
View more
Related ETFs
Updated: Tue, Dec 2
Updated: Tue, Dec 2
Name
Proportion
State Street SPDR S&P Pharmaceuticals ETF
1.91%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.36%
Invesco Dorsey Wright Healthcare Momentum ETF
1.3%
ALPS Medical Breakthroughs ETF
0.59%
Invesco Dorsey Wright SmallCap Momentum ETF
0.54%
Optimize Strategy Index ETF
0.37%
Vanguard US Momentum Factor ETF
0.22%
iShares Micro-Cap ETF
0.2%
Vanguard US Minimum Volatility ETF
0.18%
ProShares Ultra Nasdaq Biotechnology
0.14%
View more
State Street SPDR S&P Pharmaceuticals ETF
Proportion
1.91%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proportion
1.36%
Invesco Dorsey Wright Healthcare Momentum ETF
Proportion
1.3%
ALPS Medical Breakthroughs ETF
Proportion
0.59%
Invesco Dorsey Wright SmallCap Momentum ETF
Proportion
0.54%
Optimize Strategy Index ETF
Proportion
0.37%
Vanguard US Momentum Factor ETF
Proportion
0.22%
iShares Micro-Cap ETF
Proportion
0.2%
Vanguard US Minimum Volatility ETF
Proportion
0.18%
ProShares Ultra Nasdaq Biotechnology
Proportion
0.14%